{"id":"https://openalex.org/W7225729090","doi":"https://doi.org/10.25251/h29pnf69","title":"Ruxolitinib Cream Improves Clinical Outcomes in Moderate-to-Severe Non-Atopic Chronic Hand Eczema: Responses by Subtype","display_name":"Ruxolitinib Cream Improves Clinical Outcomes in Moderate-to-Severe Non-Atopic Chronic Hand Eczema: Responses by Subtype","publication_year":2026,"publication_date":"2026-11-10","ids":{"openalex":"https://openalex.org/W7225729090","doi":"https://doi.org/10.25251/h29pnf69"},"language":"en","primary_location":{"id":"doi:10.25251/h29pnf69","doi":"https://doi.org/10.25251/h29pnf69","is_oa":true,"landing_page_url":"https://doi.org/10.25251/h29pnf69","pdf_url":null,"source":{"id":"https://openalex.org/S4210210594","display_name":"SKIN The Journal of Cutaneous Medicine","issn_l":"2574-1624","issn":["2574-1624"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","poland-20"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SKIN The Journal of Cutaneous Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.25251/h29pnf69","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011094833","display_name":"Matthew Zirwas","orcid":"https://orcid.org/0000-0002-8380-8114","observed_orcids":["https://orcid.org/0000-0002-8380-8114"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthew Zirwas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025634637","display_name":"Raj Chovatiya","orcid":"https://orcid.org/0000-0001-6510-399X","observed_orcids":["https://orcid.org/0000-0001-6510-399X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Raj Chovatiya","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079997007","display_name":"Benjamin D. Ehst","orcid":"https://orcid.org/0000-0001-6380-5226","observed_orcids":["https://orcid.org/0000-0001-6380-5226"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Benjamin D. Ehst","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021512300","display_name":"Christina Feser","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christina Feser","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043598869","display_name":"Nicole M. Chase","orcid":"https://orcid.org/0000-0003-1592-169X","observed_orcids":["https://orcid.org/0000-0003-1592-169X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nicole M. Chase","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041911128","display_name":"Dareen D. Siri","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dareen D. Siri","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029971595","display_name":"Robert Bissonnette","orcid":"https://orcid.org/0000-0001-5927-6587","observed_orcids":["https://orcid.org/0000-0001-5927-6587"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert Bissonnette","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5145986093","display_name":"Thomas Werfel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas Werfel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092216049","display_name":"Philippa Halden","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Philippa Halden","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161411880","display_name":"Haobo Ren","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Haobo Ren","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047889924","display_name":"A. B. Gutman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ari B. Gutman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5132811968","display_name":"L. Stein Gold","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Linda F. Stein Gold","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"10","issue":"6","first_page":"s887","last_page":"s887"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.8984000086784363,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.8984000086784363,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11033","display_name":"Contact Dermatitis and Allergies","score":0.09629999846220016,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[],"concepts":[{"id":"https://openalex.org/C2776112149","wikidata":"https://www.wikidata.org/wiki/Q7383611","display_name":"Ruxolitinib","level":4,"score":0.9470999836921692},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9415000081062317},{"id":"https://openalex.org/C2780699399","wikidata":"https://www.wikidata.org/wiki/Q20708049","display_name":"Eczema Area and Severity Index","level":3,"score":0.7527999877929688},{"id":"https://openalex.org/C2778329239","wikidata":"https://www.wikidata.org/wiki/Q268667","display_name":"Atopic dermatitis","level":2,"score":0.6312999725341797},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6189000010490417},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5654000043869019},{"id":"https://openalex.org/C2776233030","wikidata":"https://www.wikidata.org/wiki/Q17149812","display_name":"Janus kinase inhibitor","level":4,"score":0.5403000116348267},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.49729999899864197},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.4650000035762787},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4560000002384186},{"id":"https://openalex.org/C2778750689","wikidata":"https://www.wikidata.org/wiki/Q1799146","display_name":"Irritant contact dermatitis","level":4,"score":0.4343999922275543},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4034999907016754},{"id":"https://openalex.org/C2781418243","wikidata":"https://www.wikidata.org/wiki/Q1574795","display_name":"Hand eczema","level":4,"score":0.3621000051498413},{"id":"https://openalex.org/C2992886853","wikidata":"https://www.wikidata.org/wiki/Q18381816","display_name":"Post hoc","level":2,"score":0.320499986410141},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.31040000915527344},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.29829999804496765},{"id":"https://openalex.org/C30036603","wikidata":"https://www.wikidata.org/wiki/Q17125150","display_name":"Severity of illness","level":2,"score":0.2840999960899353},{"id":"https://openalex.org/C205545832","wikidata":"https://www.wikidata.org/wiki/Q17156455","display_name":"Young adult","level":2,"score":0.28299999237060547},{"id":"https://openalex.org/C2778091633","wikidata":"https://www.wikidata.org/wiki/Q783903","display_name":"Contact dermatitis","level":3,"score":0.2825999855995178},{"id":"https://openalex.org/C2776056826","wikidata":"https://www.wikidata.org/wiki/Q16242752","display_name":"Allergic contact dermatitis","level":3,"score":0.2632000148296356},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.26159998774528503},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.26019999384880066},{"id":"https://openalex.org/C2780401118","wikidata":"https://www.wikidata.org/wiki/Q4734616","display_name":"Alopecia universalis","level":3,"score":0.2590000033378601}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.25251/h29pnf69","doi":"https://doi.org/10.25251/h29pnf69","is_oa":true,"landing_page_url":"https://doi.org/10.25251/h29pnf69","pdf_url":null,"source":{"id":"https://openalex.org/S4210210594","display_name":"SKIN The Journal of Cutaneous Medicine","issn_l":"2574-1624","issn":["2574-1624"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","poland-20"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SKIN The Journal of Cutaneous Medicine","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.25251/h29pnf69","doi":"https://doi.org/10.25251/h29pnf69","is_oa":true,"landing_page_url":"https://doi.org/10.25251/h29pnf69","pdf_url":null,"source":{"id":"https://openalex.org/S4210210594","display_name":"SKIN The Journal of Cutaneous Medicine","issn_l":"2574-1624","issn":["2574-1624"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","poland-20"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SKIN The Journal of Cutaneous Medicine","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Chronic":[0],"hand":[1,30,341],"eczema":[2],"(CHE)":[3],"is":[4],"characterized":[5],"by":[6,74,171],"persistent":[7],"or":[8,106,294],"recurrent":[9],"inflammatory":[10],"lesions":[11,124],"on":[12],"the":[13,247],"hands":[14],"and":[15,28,52,95,154,222,270,303,305],"wrists.":[16],"Ruxolitinib":[17],"(Janus":[18],"kinase":[19],"[JAK]1/JAK2":[20],"inhibitor)":[21],"cream":[22,46,105,121,217,283,319,345],"has":[23],"demonstrated":[24,50],"efficacy":[25,53],"in":[26,37,128,160,323,328,334,339],"atopic":[27,97,340],"nonatopic":[29,41],"eczema.":[31],"In":[32,316],"a":[33,129,145,155,347],"phase":[34],"2":[35],"study":[36],"adults":[38],"with":[39,57,63,78,144,215,250,281,297,325,336,353],"moderate-to-severe":[40,326],"CHE":[42,75,172,327,354],"(NCT05906628),":[43],"1.5%":[44,103,119],"ruxolitinib":[45,104,120,216,254,282,318,344],"twice":[47],"daily":[48],"(BID)":[49],"tolerability":[51],"at":[54,212,260,266,278],"Week":[55,61,213,261,267,279,289],"16,":[56],"improvements":[58],"maintained":[59,293],"to":[60,102,122,253],"32":[62],"as-needed":[64,298],"BID":[65,108,125],"treatment.":[66,114],"This":[67],"post":[68],"hoc":[69],"analysis":[70],"evaluated":[71,169,330],"clinical":[72,223,321],"outcomes":[73,167,322],"subtype.":[76,173,357],"Adults":[77],"CHE,":[79],"Investigator\u2019s":[80],"Global":[81],"Assessment":[82],"(IGA)-CHE":[83],"score":[84,93,139],"of":[85,112,136,140,356],"3/4":[86],"(moderate/severe),":[87],"CHE-related":[88],"Itch":[89],"Numerical":[90],"Rating":[91],"Scale":[92],"\u22654,":[94],"no":[96],"dermatitis":[98,180,186,194],"were":[99,168,210,274,292],"randomized":[100,176],"1:1":[101],"vehicle":[107,219,285,311],"for":[109,300,351],"16":[110,214,262,280],"weeks":[111],"double-blind":[113],"All":[115],"patients":[116,177,306,324,352],"then":[117],"applied":[118],"active":[123],"as":[126,346],"needed":[127],"16-week":[130],"open-label":[131],"extension.":[132],"Outcomes":[133],"included":[134],"achievement":[135],"an":[137],"IGA-CHE":[138],"0/1":[141],"(clear/almost":[142],"clear)":[143],"\u22652-grade":[146],"improvement":[147,157],"from":[148,158,310],"baseline":[149,159],"(IGA-CHE":[150],"treatment":[151,299,349],"success":[152],"[IGA-CHE-TS])":[153],"\u226575%/\u226590%":[156],"Hand":[161],"Eczema":[162],"Severity":[163],"Index":[164],"(HECSI-75/HECSI-90).":[165],"As-observed":[166],"descriptively":[170],"Among":[174],"186":[175],"(allergic":[178],"contact":[179,183,185,193],"[ACD],":[181],"n=30;":[182],"urticaria/protein":[184],"[CU/PCD],":[187],"n=1;":[188],"hyperkeratotic":[189,229],"eczema,":[190,198,230,239,342],"n=26;":[191],"irritant":[192],"[ICD],":[195],"n=51;":[196],"vesicular":[197,238],"n=28;":[199],"unclassified,":[200,243],"n=60;":[201],"subtypes":[202,224,302],"not":[203,257],"mutually":[204],"exclusive),":[205],"greater":[206,277],"IGA-CHE-TS":[207,259],"response":[208,272],"rates":[209,273],"observed":[211],"versus":[218,284],"across":[220,286],"etiologic":[221],"(ACD,":[225],"46.7%":[226],"vs":[227,232,236,241,245],"20.0%;":[228],"63.6%":[231],"16.7%;":[233],"ICD,":[234],"56.0%":[235],"9.1%;":[237],"61.5%":[240,244],"0%;":[242],"15.4%);":[246],"1":[248],"patient":[249],"CU/PCD":[251],"(randomized":[252],"cream)":[255],"did":[256,264],"achieve":[258],"but":[263],"so":[265],"32.":[268],"HECSI-75":[269],"HECSI-90":[271],"also":[275],"substantially":[276,313],"subtypes.":[287,331],"At":[288],"32,":[290],"responses":[291],"further":[295],"improved":[296,314,320],"most":[301],"endpoints,":[304],"who":[307],"crossed":[308],"over":[309],"had":[312],"responses.":[315],"summary,":[317],"all":[329],"These":[332],"results,":[333],"combination":[335],"existing":[337],"data":[338],"support":[343],"potential":[348],"option":[350],"irrespective":[355],"(Funding,":[358],"Incyte":[359],"Corporation).":[360]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-11T00:00:00"}